Towards setting breakpoints for oxolinic acid susceptibility of Aeromonas salmonicida using distribution of data generated by standard test protocols

The breakpoints estimated in this work are compared to those estimated by other workers from data generated from different protocols. The issue of the clinical relevance of the breakpoints generated from the distribution of susceptibility data is discussed.